-
Edwards Lifesciences Gains 8% Following Positive Trial
Monday, April 4, 2016 - 7:36am | 280Shares of Edwards Lifesciences Corp (NYSE: EW) gained more than 8 percent early Monday morning after the company announced over the weekend results from a clinical study involving patients at intermediate risk for open-heart surgery. Edwards Lifesciences stated its data showed that patients at...